These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of pattern-reversal electroretinography in the diagnosis of glaucoma. Kreuz AC; Oyamada MK; Hatanaka M; Monteiro ML Arq Bras Oftalmol; 2014; 77(6):403-10. PubMed ID: 25627192 [TBL] [Abstract][Full Text] [Related]
5. Correlation between photopic negative response and retinal nerve fiber layer thickness and optic disc topography in glaucomatous eyes. Machida S; Gotoh Y; Toba Y; Ohtaki A; Kaneko M; Kurosaka D Invest Ophthalmol Vis Sci; 2008 May; 49(5):2201-7. PubMed ID: 18436853 [TBL] [Abstract][Full Text] [Related]
6. Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma. Fortune B; Bearse MA; Cioffi GA; Johnson CA Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2638-47. PubMed ID: 12147597 [TBL] [Abstract][Full Text] [Related]
7. [Oscillatory potentials in the diagnosis of glaucoma optic neuropathy]. Shamshinova AM; Vazhenkov SN; Robustova OV; Seidova FG Vestn Oftalmol; 2010; 126(1):15-20. PubMed ID: 20645569 [TBL] [Abstract][Full Text] [Related]
8. Disease progression and the need for neuroprotection in glaucoma management. Varma R; Peeples P; Walt JG; Bramley TJ Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311 [TBL] [Abstract][Full Text] [Related]
9. A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy. Caprioli J; Zeyen T J Glaucoma; 2009 Aug; 18(6 Suppl):S1-21. PubMed ID: 19680047 [TBL] [Abstract][Full Text] [Related]
11. [Glaucomatous optic neuropathy. Its etiopathogenetic aspects; the therapeutic consequences]. Apostol S Oftalmologia; 1998; 44(3):13-6. PubMed ID: 10418606 [TBL] [Abstract][Full Text] [Related]
12. [Current theory on mechanical damage in glaucomatous optic neuropathy]. Nizankowska MH; Turno-Krecicka A Klin Oczna; 1997; 99(3):211-5. PubMed ID: 9456570 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies. Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180 [TBL] [Abstract][Full Text] [Related]
14. Optic neuropathies--importance of spatial distribution of mitochondria as well as function. Yu Wai Man CY; Chinnery PF; Griffiths PG Med Hypotheses; 2005; 65(6):1038-42. PubMed ID: 16098682 [TBL] [Abstract][Full Text] [Related]
15. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration. Schwartz M; Belkin M; Yoles E; Solomon A J Glaucoma; 1996 Dec; 5(6):427-32. PubMed ID: 8946301 [TBL] [Abstract][Full Text] [Related]
16. Glaucoma and the brain. Insight; 2012; 37(3):22. PubMed ID: 22970483 [No Abstract] [Full Text] [Related]
17. Analysis of retinal nerve fiber layer and optic nerve head in glaucoma with different reference plane offsets, using optical coherence tomography. Leung CK; Chan WM; Hui YL; Yung WH; Woo J; Tsang MK; Tse KK Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):891-9. PubMed ID: 15728545 [TBL] [Abstract][Full Text] [Related]
18. [Glaucoma as primary optic neuropathy]. Nicolae A; Stefan C Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602 [TBL] [Abstract][Full Text] [Related]
19. Optic disc and visual field changes after trabeculectomy. Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A; Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409 [TBL] [Abstract][Full Text] [Related]